Nitin Sahney has been the Chief Executive Officer and President of Omnicare Inc. since June 30, 2014 and September 11, 2012 respectively. Mr. Sahney served as the Chief Operating Officer at Omnicare Inc. from September 11, 2012 to June 30, 2014. He served as the President of Specialty Care Group at Omnicare Inc. since November 10, 2010. Mr. Sahney served as an Executive Vice President of Omnicare Inc since November 1, 2010. He served as the President of RxCrossroads LLC since January 2005 and served as its Chief Executive Officer. In early 2001 Mr. Sahney joined RxCrossroads' parent organization as Executive Vice President. He co-founded RxCrossroads™. He was responsible for growing RxCrossroads™ into the premier provider of reimbursement, specialty distribution, and clinical services to the pharmaceutical and biologics industries. Mr. Sahney has 10 years of varied healthcare experience working for two world-class healthcare organizations. Following a brief stint in finance for a New York based investment firm, He joined Caremark as a Reimbursement Manager. There, Mr. Sahney spent two years in the operations of one of the country's top home health providers. Mr. Sahney joined Cardinal Healthcare Inc. in 1994. In 1997 he moved to Cardinal's corporate office, where Mr. Sahney served as Director of Business Development. He was one of the key members of the due diligence team during the acquisitions to develop this business. Mr. Sahney's healthcare experience spanned over several Fortune 100 healthcare companies such as Cardinal Health and Caremark. He serves as a Director of RxCrossroads, LLC. He serves as a Director of Cincinnati USA Regional Chamber. He has been a Director of Omnicare Inc. since June 30, 2014. After two years Mr. Sahney was named the youngest GM in Cardinal and took on responsibility for all of Nexus. Mr. Sahney has a B.S. in Economics from Punjab University and an MBA from Clarion University in Pennsylvania.
Omnicare is an American company working in the health care industry, established in April 1981.
In 2012, the Federal Trade Commission (FTC) sued Omnicare to block its hostile takeover of its rival PharMerica under federal anti-trust law. The FTC alleged that the acquisition would boost drug costs and inflate Medicare expenditures by consolidating the industry and reducing price competition.[1] PharMerica owned 97 long-term-care pharmacies, while Omnicare owned approximately 200. The merger would have given Omnicare a 57% marketshare versus two percent for its nearest, non-PharMerica rival.[2] Because of the FTC opposition, the takeover was terminated.
